Health Condition 1: A190- Acute miliary tuberculosis of a single specified site Health Condition 2: A191- Acute miliary tuberculosis of multiple sites Health Condition 3: A192- Acute miliary tuberculosis, unspecified Health Condition 4: A171- Meningeal tuberculoma Health Condition 5: A199- Miliary tuberculosis, unspecified Health Condition 6: A198- Other miliary tuberculosis Health Condition 7: A158- Other respiratory tuberculosis Health Condition 8: A178- Other tuberculosis of nervous system He
Conditions
Interventions
Intervention1: NIL: NIL
Intervention2: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Intramural Funding, MAHE, Manipal
Eligibility
Inclusion criteria
Inclusion criteria: 1) Microbiologically confirmed pulmonary and extrapulmonary TB cases 2) Inpatients
Exclusion criteria
Exclusion criteria: 1) TB patient with mental illness 2) Pregnant women with TB
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. The study could provide valuable information on the impact of M. tuberculosis lineage, antitubercular resistance, and demographic, and clinical data on TB patients’ outcomes. 2. Comprehensive surveillance by WGS could complement phenotypic DST in selecting precise antitubercular drug therapy for TB patients. 3. Lineage-specific variations could help decipher drug resistance mutations.Timepoint: 3 years | — |
Secondary
| Measure | Time frame |
|---|---|
| The study could add important information for regional and national policymaking for appropriate antitubercular drug and dose selectionTimepoint: 3 years | — |
Countries
India
Contacts
Public ContactMr Shrivathsa K N
Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal
Outcome results
None listed